( Log in to your Wikimedia account to use OAuth instead of Quickstatements for updates.)

Author name:
Limit:
Additional SPARQL filters separated by semicolons (eg. for papers on Zika virus, enter wdt:P921 wd:Q202864):
Filter potential authors as well?

Potential publications

50 publications found

Warning: limit reached; process these papers and then reload to see if there are more for this author name string
Click here to create clusters based on exact author strings rather than rougher matches.

Group #1

Matched potential author: Bryan L. Roth - author of 44 items
TitleAuthors (identified)Published InIdentifier(s)TopicPublished DateMatch?
In Vitro and In Vivo Characterization of the Alkaloid Nuciferine[1]Martilias S Farrell, [2]John D McCorvy, [3]Xi-Ping Huang, [4]Daniel J Urban, [5]Kate L White, [6]Patrick M Giguere, [7]Allison K Doak, [8]Alison I Bernstein, [9]Kristen A Stout, [10]Su Mi Park, ..., [20]William E Fantegrossi, [21]William C Wetsel, [22]Bryan L Roth [Full author list]PLOS One [missing]DOI: 10.1371/JOURNAL.PONE.0150602 [ORCID]
PubMed: 26963248 [ORCID]
2016-03-10Bryan L. Roth (Q89688393; 44 items)
Allosteric ligands for the pharmacologically dark receptors GPR68 and GPR65[1]Xi-Ping Huang, [2]Joel Karpiak, [3]Wesley K Kroeze, [4]Hu Zhu, [5]Xin Chen, [6]Sheryl S Moy, [7]Kara A Saddoris, [8]Viktoriya D Nikolova, [9]Martilias S Farrell, [10]Sheng Wang, [11]Thomas J Mangano, [12]Deepak A Deshpande, [13]Alice Jiang, [14]Raymond B Penn, [15]Jian Jin, [16]Beverly H Koller, [17]Terry Kenakin, [18]Brian K Shoichet, [19]Bryan L Roth [Full author list]Nature [missing]DOI: 10.1038/NATURE15699 [ORCID]
PubMed: 26550826 [ORCID]
pharmacology [missing]2015-11-09Bryan L. Roth (Q89688393; 44 items)
Novel molecular targets of dezocine and their clinical implications[1]Renyu Liu, [2]Xi-Ping Huang, [3]Alexei Yeliseev, [4]Jin Xi, [5]Bryan L Roth [Full author list]Anesthesiology [missing]DOI: 10.1097/ALN.0000000000000076 [ORCID]
PubMed: 24263237 [ORCID]
pain [missing]; anaesthesiology [missing]2014-03-01Bryan L. Roth (Q89688393; 44 items)
Chemogenetic inactivation of ventral hippocampal glutamatergic neurons disrupts consolidation of contextual fear memory[1]Hu Zhu, [2]Kristen E Pleil, [3]Daniel J Urban, [4]Sheryl S Moy, [5]Thomas L Kash, [6]Bryan L Roth [Full author list]Neuropsychopharmacology [missing]DOI: 10.1038/NPP.2014.35 [ORCID]
PubMed: 24525710 [ORCID]
fear memory [missing]2014-02-14Bryan L. Roth (Q89688393; 44 items)
The ketamine analogue methoxetamine and 3- and 4-methoxy analogues of phencyclidine are high affinity and selective ligands for the glutamate NMDA receptor[1]Bryan L Roth, [2]Simon Gibbons, [3]Warunya Arunotayanun, [4]Xi-Ping Huang, [5]Vincent Setola, [6]Ric Treble, [7]Les Iversen [Full author list]PLOS One [missing]DOI: 10.1371/JOURNAL.PONE.0059334 [ORCID]
PubMed: 23527166 [ORCID]
2013-01-01Bryan L. Roth (Q89688393; 44 items)
Marine algal toxin azaspiracid is an open-state blocker of hERG potassium channels[1]Michael J Twiner, [2]Gregory J Doucette, [3]Andrew Rasky, [4]Xi-Ping Huang, [5]Bryan L Roth, [6]Michael C Sanguinetti [Full author list]Chemical Research in Toxicology [missing]DOI: 10.1021/TX300283T [ORCID]
PubMed: 22856456 [ORCID]
2012-08-10Bryan L. Roth (Q89688393; 44 items)
Topoisomerase inhibitors unsilence the dormant allele of Ube3a in neurons[1]Hsien-Sung Huang, [2]John A Allen, [3]Angela M Mabb, [4]Ian F King, [5]Jayalakshmi Miriyala, [6]Bonnie Taylor-Blake, [7]Noah Sciaky, [8]J Walter Dutton, [9]Hyeong-Min Lee, [10]Xin Chen, [11]Jian Jin, [12]Arlene S Bridges, [13]Mark J. Zylka, [14]Bryan L Roth, [15]Benjamin D Philpot [Full author list]Nature [missing]DOI: 10.1038/NATURE10726 [ORCID]
PubMed: 22190039 [ORCID]
topotecan [missing]2012-01-12Bryan L. Roth (Q89688393; 44 items)
Parallel functional activity profiling reveals valvulopathogens are potent 5-hydroxytryptamine(2B) receptor agonists: implications for drug safety assessment[1]Xi-Ping Huang, [2]Vincent Setola, [3]Prem N Yadav, [4]John A Allen, [5]Sarah C Rogan, [6]Bonnie J Hanson, [7]Chetana Revankar, [8]Matt Robers, [9]Chris Doucette, [10]Bryan L Roth [Full author list]Molecular Pharmacology [missing]DOI: 10.1124/MOL.109.058057 [ORCID]
PubMed: 19570945 [ORCID]
2009-10-01Bryan L. Roth (Q89688393; 44 items)
Amisulpride is a potent 5-HT7 antagonist: relevance for antidepressant actions in vivo[1]Atheir I Abbas, [2]Peter B Hedlund, [3]Xi-Ping Huang, [4]Thuy B Tran, [5]Herbert Y. Meltzer, [6]Bryan L Roth, [6-Q89688393]Bryan L. Roth [Full author list]Psychopharmacology [missing]DOI: 10.1007/S00213-009-1521-8 [ORCID]
PubMed: 19337725 [ORCID]
2009-07-01Bryan L. Roth (Q89688393; 44 items)
Remote control of neuronal activity in transgenic mice expressing evolved G protein-coupled receptors[1]Georgia M Alexander, [2]Sarah C Rogan, [3]Atheir I Abbas, [4]Blaine N Armbruster, [5]Ying Pei, [6]John A Allen, [7]Randal J Nonneman, [8]John Hartmann, [9]Sheryl S Moy, [10]Miguel A Nicolelis, [11]James O McNamara, [12]Bryan L Roth [Full author list]Neuron [missing]DOI: 10.1016/J.NEURON.2009.06.014 [ORCID]
PubMed: 19607790 [ORCID]
G protein-coupled receptor [missing]2009-07-01Bryan L. Roth (Q89688393; 44 items)

Group #2

Matched potential author: Bryan L. Roth - author of 44 items
TitleAuthors (identified)Published InIdentifier(s)TopicPublished DateMatch?
Evidence for the involvement of dopamine transporters in behavioral stimulant effects of modafinil[1]Dorota Zolkowska, [2]Raka Jain, [3]Richard B. Rothman, [4]John S Partilla, [5]Bryan L Roth, [6]Vincent Setola, [7]Thomas E Prisinzano, [8]Michael H Baumann [Full author list]Journal of Pharmacology and Experimental Therapeutics [missing]DOI: 10.1124/JPET.108.146142 [ORCID]
PubMed: 19197004 [ORCID]
dopamine [missing]; modafinil [missing]2009-02-05Bryan L. Roth (Q89688393; 44 items)
p90 ribosomal S6 kinase 2 exerts a tonic brake on G protein-coupled receptor signaling[1]Douglas J Sheffler, [2]Wesley K Kroeze, [3]Bonnie G Garcia, [4]Ariel Y Deutch, [5]Sandra J Hufeisen, [6]Patrick Leahy, [7]Jens C Brüning, [8]Bryan L Roth [Full author list]Proceedings of the National Academy of Sciences of the United States of America [missing]DOI: 10.1073/PNAS.0600585103 [ORCID]
PubMed: 16537434 [ORCID]
G protein-coupled receptor [missing]; Ribosomal protein S6 kinase polypeptide 3 [missing]2006-03-10Bryan L. Roth (Q89688393; 44 items)
Molecular determinants for the interaction of the valvulopathic anorexigen norfenfluramine with the 5-HT2B receptor[1]Vincent Setola, [2]Malgorzata Dukat, [3]Richard A Glennon, [4]Bryan L Roth [Full author list]Molecular Pharmacology [missing]DOI: 10.1124/MOL.104.009266 [ORCID]
PubMed: 15831837 [ORCID]
5-hydroxytryptamine receptor 2A [missing]; 5-hydroxytryptamine receptor 2B [missing]; serotonin binding [missing]; 5-hydroxytryptamine receptor 2C [missing]2005-07-01
Development of a rationally designed, low abuse potential, biogenic amine releaser that suppresses cocaine self-administration[1]Richard B. Rothman, [2]Bruce E Blough, [3]William L Woolverton, [4]Karen G Anderson, [5]S Stevens Negus, [6]Nancy K Mello, [7]Bryan L Roth, [8]Michael H Baumann [Full author list]Journal of Pharmacology and Experimental Therapeutics [missing]DOI: 10.1124/JPET.104.082503 [ORCID]
PubMed: 15761112 [ORCID]
cocaine [missing]2005-06-01
The human polyomavirus, JCV, uses serotonin receptors to infect cells[1]Gwendolyn F Elphick, [2]William Querbes, [3]Joslynn A Jordan, [4]Gretchen V Gee, [5]Sylvia Eash, [6]Kate Manley, [7]Aisling Dugan, [8]Megan Stanifer, [9]Anushree Bhatnagar, [10]Wesley K Kroeze, [11]Bryan L Roth, [12]Walter J Atwood [Full author list]Science [missing]DOI: 10.1126/SCIENCE.1103492 [ORCID]
PubMed: 15550673 [ORCID]
serotonin [missing]; Human polyomavirus [missing]2004-11-19Bryan L. Roth (Q89688393; 44 items)
Caveolin-1 interacts with 5-HT2A serotonin receptors and profoundly modulates the signaling of selected Galphaq-coupled protein receptors[1]Anushree Bhatnagar, [2]Douglas J Sheffler, [3]Wesley K Kroeze, [4]BethAnn Compton-Toth, [5]Bryan L Roth [Full author list]Journal of Biological Chemistry [missing]DOI: 10.1074/JBC.M404673200 [ORCID]
PubMed: 15190056 [ORCID]
serotonin [missing]2004-08-13Bryan L. Roth (Q89688393; 44 items)
Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia[1]Bryan L Roth, [2]Douglas J Sheffler, [3]Wesley K Kroeze [Full author list]Nature Reviews Drug Discovery [missing]DOI: 10.1038/NRD1346 [ORCID]
PubMed: 15060530 [ORCID]
schizophrenia [missing]; mood disorder [missing]2004-04-01Bryan L. Roth (Q89688393; 44 items)
3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") induces fenfluramine-like proliferative actions on human cardiac valvular interstitial cells in vitro[1]Vincent Setola, [2]Sandra J Hufeisen, [3]Jane Grande-Allen, [4]Ivan Vesely, [5]Richard A Glennon, [6]Bruce Blough, [7]Richard B. Rothman, [8]Bryan L Roth [Full author list]Molecular Pharmacology [missing]DOI: 10.1124/MOL.63.6.1223 [ORCID]
PubMed: 12761331 [ORCID]
2003-06-01Bryan L. Roth (Q89688393; 44 items)
Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist[1]Bryan L Roth, [2]Karen Baner, [3]Richard Westkaemper, [4]Daniel Siebert, [5]Kenner C Rice, [6]SeAnna Steinberg, [7]Paul Ernsberger, [8]Richard B. Rothman [Full author list]Proceedings of the National Academy of Sciences of the United States of America [missing]DOI: 10.1073/PNAS.182234399 [ORCID]
PubMed: 12192085 [ORCID]
opioid [missing]2002-08-21Bryan L. Roth (Q89688393; 44 items)

Group #3

Matched potential author: Bryan L. Roth - author of 44 items
TitleAuthors (identified)Published InIdentifier(s)TopicPublished DateMatch?
Zebrafish behavioral profiling identifies multitarget antipsychotic-like compounds[1]Giancarlo Bruni, [2]Andrew J. Rennekamp, [3]Andrea Velenich, [4]Matthew McCarroll, [5]Leo Gendelev, [6]Ethan Fertsch, [7]Jack Taylor, [8]Parth Lakhani, [9]Dennis Lensen, [10]Tama Evron, [11]Paul J Lorello, [12]Xi-Ping Huang, [13]Sabine Kolczewski, [14]Galen Carey, [15]Barbara J Caldarone, [16]Eric Prinssen, [17]Bryan L Roth, [18]Michael J Keiser, [19]Randall T Peterson, [20]David Kokel [Full author list]Nature Chemical Biology [missing]DOI: 10.1038/NCHEMBIO.2097 [ORCID]
PubMed: 27239787 [ORCID]
Danio rerio [missing]2016-05-30Bryan L. Roth (Q89688393; 44 items)
Single Amino Acid Variation Underlies Species-Specific Sensitivity to Amphibian Skin-Derived Opioid-like Peptides[1]Eyal Vardy, [2]Maria F Sassano, [3]Andrew J. Rennekamp, [4]Wesley K Kroeze, [5]Philip D Mosier, [6]Richard B Westkaemper, [7]Craig W Stevens, [8]Vsevolod Katritch, [9]Raymond C Stevens, [10]Randall T Peterson, [11]Bryan L Roth [Full author list]Chemistry and Biology [missing]DOI: 10.1016/J.CHEMBIOL.2015.05.012 [ORCID]
PubMed: 26091169 [ORCID]
opioid [missing]; clinical chemistry [missing]; drug discovery [missing]2015-06-01Bryan L. Roth (Q89688393; 44 items)
In silico molecular comparisons of C. elegans and mammalian pharmacology identify distinct targets that regulate feeding[1]George A Lemieux, [2]Michael J Keiser, [3]Maria F Sassano, [4]Christian Laggner, [5]Fahima Mayer, [6]Roland J Bainton, [7]Zena Werb, [8]Bryan L Roth, [9]Brian K. Shoichet, [10]Kaveh Ashrafi [Full author list]PLOS Biology [missing]DOI: 10.1371/JOURNAL.PBIO.1001712 [ORCID]
PubMed: 24260022 [ORCID]
Caenorhabditis elegans [missing]; pharmacology [missing]2013-11-01Bryan L. Roth (Q89688393; 44 items)
The presynaptic component of the serotonergic system is required for clozapine's efficacy[1]Prem N Yadav, [2]Atheir I Abbas, [3]Martilias S Farrell, [4]Vincent Setola, [5]Noah Sciaky, [6]Xi-Ping Huang, [7]Wesley K Kroeze, [8]LaTasha K Crawford, [9]David A Piel, [10]Michael J Keiser, [11]John J Irwin, [12]Brian K Shoichet, [13]Evan S Deneris, [14]Jay Gingrich, [15]Sheryl G Beck, [16]Bryan L Roth [Full author list]Neuropsychopharmacology [missing]DOI: 10.1038/NPP.2010.195 [ORCID]
PubMed: 21048700 [ORCID]
2010-11-03Bryan L. Roth (Q89688393; 44 items)
9-Aminomethyl-9,10-dihydroanthracene (AMDA) analogs as structural probes for steric tolerance in 5-HT2A and H1 receptor binding sites[1]Jitesh R Shah, [2]Philip D Mosier, [3]Srinivas Peddi, [4]Bryan L Roth, [5]Richard B Westkaemper [Full author list]Bioorganic & Medicinal Chemistry Letters [missing]DOI: 10.1016/J.BMCL.2009.12.064 [ORCID]
PubMed: 20045641 [ORCID]
organic chemistry [missing]; drug discovery [missing]2010-02-01
Predicting new molecular targets for known drugs[1]Michael J Keiser, [2]Vincent Setola, [3]John J Irwin, [4]Christian Laggner, [5]Atheir I Abbas, [6]Sandra J Hufeisen, [7]Niels H Jensen, [8]Michael B Kuijer, [9]Roberto C Matos, [10]Thuy B Tran, [11]Ryan Whaley, [12]Richard A Glennon, [13]Jérôme Hert, [14]Kelan Thomas, [15]Douglas D Edwards, [16]Brian K. Shoichet, [17]Bryan L Roth [Full author list]Nature [missing]DOI: 10.1038/NATURE08506 [ORCID]
PubMed: 19881490 [ORCID]
2009-11-01Bryan L. Roth (Q89688393; 44 items)
Potential modes of interaction of 9-aminomethyl-9,10-dihydroanthracene (AMDA) derivatives with the 5-HT2A receptor: a ligand structure-affinity relationship, receptor mutagenesis and receptor modeling investigation[1]Scott P Runyon, [2]Philip D Mosier, [3]Bryan L Roth, [4]Richard A Glennon, [5]Richard B Westkaemper [Full author list]Journal of Medicinal Chemistry [missing]DOI: 10.1021/JM800771X [ORCID]
PubMed: 18847250 [ORCID]
drug discovery [missing]2008-11-13
Methoxy-substituted 9-aminomethyl-9,10-dihydroanthracene (AMDA) derivatives exhibit differential binding affinities at the 5-HT(2A) receptor[1]Gajanan K Dewkar, [2]Srinivas Peddi, [3]Philip D Mosier, [4]Bryan L Roth, [5]Richard B Westkaemper [Full author list]Bioorganic & Medicinal Chemistry Letters [missing]DOI: 10.1016/J.BMCL.2008.08.059 [ORCID]
PubMed: 18774714 [ORCID]
organic chemistry [missing]; drug discovery [missing]2008-10-01
Binding of sulfonyl-containing arylalkylamines at human 5-HT6 serotonin receptors[1]Donald Sikazwe, [2]Mikhail L Bondarev, [3]Małgorzata Dukat, [4]Jagadeesh B Rangisetty, [5]Bryan L Roth, [6]Richard A Glennon [Full author list]Journal of Medicinal Chemistry [missing]DOI: 10.1021/JM060469Q [ORCID]
PubMed: 16913710 [ORCID]
serotonin [missing]2006-08-24
1-(1-Naphthyl)piperazine as a novel template for 5-HT6 serotonin receptor ligands[1]Mase Lee, [2]Jagadeesh B Rangisetty, [3]Manik R Pullagurla, [4]Małgorzata Dukat, [5]Vince Setola, [6]Bryan L Roth, [7]Richard A Glennon [Full author list]Bioorganic & Medicinal Chemistry Letters [missing]DOI: 10.1016/J.BMCL.2005.01.031 [ORCID]
PubMed: 15745826 [ORCID]
serotonin [missing]2005-03-15
Spiro[9,10-dihydroanthracene]-9,3'-pyrrolidine-a structurally unique tetracyclic 5-HT2A receptor antagonist[1]Srinivas Peddi, [2]Bryan L Roth, [3]Richard A Glennon, [4]Richard B Westkaemper [Full author list]European Journal of Pharmacology [missing]DOI: 10.1016/J.EJPHAR.2003.09.059 [ORCID]
PubMed: 14660041 [ORCID]
2003-12-15

Group #4

Matched potential author: Bryan L. Roth - author of 44 items
TitleAuthors (identified)Published InIdentifier(s)TopicPublished DateMatch?
The G protein-biased κ-opioid receptor agonist RB-64 is analgesic with a unique spectrum of activities in vivo[1]Kate L White, [2]J Elliott Robinson, [3]Hu Zhu, [4]Jeffrey F DiBerto, [5]Prabhakar R Polepally, [6]Jordan Zjawiony, [7]David E Nichols, [8]C J Malanga, [9]Bryan L Roth [Full author list]Journal of Pharmacology and Experimental Therapeutics [missing]DOI: 10.1124/JPET.114.216820 [ORCID]
PubMed: 25320048 [ORCID]
opioid [missing]; bias [missing]2014-10-15Bryan L. Roth (Q89688393; 44 items)
Structure-based design, synthesis, and biochemical and pharmacological characterization of novel salvinorin A analogues as active state probes of the kappa-opioid receptor[1]Feng Yan, [2]Ruslan V Bikbulatov, [3]Viorel Mocanu, [4]Nedyalka Dicheva, [5]Carol E Parker, [6]William C Wetsel, [7]Philip D Mosier, [8]Richard B Westkaemper, [9]John A Allen, [10]Jordan Zjawiony, [11]Bryan L Roth [Full author list]Biochemistry [missing]DOI: 10.1021/BI900605N [ORCID]
PubMed: 19555087 [ORCID]
biochemistry [missing]; pharmacology [missing]; opioid [missing]; active state [missing]2009-07-01Bryan L. Roth (Q89688393; 44 items)
Studies toward the pharmacophore of salvinorin A, a potent kappa opioid receptor agonist[1]Thomas A. Munro, [2]Mark A Rizzacasa, [3]Bryan L Roth, [4]Beth A Toth, [5]Feng Yan [Full author list]Journal of Medicinal Chemistry [missing]DOI: 10.1021/JM049438Q [ORCID]
PubMed: 15658846 [ORCID]
opioid [missing]; drug discovery [missing]2005-01-01
Salvinorin A, an active component of the hallucinogenic sage salvia divinorum is a highly efficacious kappa-opioid receptor agonist: structural and functional considerations[1]Charles Chavkin, [2]Sumit Sud, [3]Wenzhen Jin, [4]Jeremy Stewart, [5]Jordan Zjawiony, [6]Daniel J Siebert, [7]Beth Ann Toth, [8]Sandra J Hufeisen, [9]Bryan L Roth [Full author list]Journal of Pharmacology and Experimental Therapeutics [missing]DOI: 10.1124/JPET.103.059394 [ORCID]
PubMed: 14718611 [ORCID]
Salvia divinorum [missing]; opioid [missing]2004-01-08Bryan L. Roth (Q89688393; 44 items)

Misc

Matched potential author: Bryan L. Roth - author of 44 items
TitleAuthors (identified)Published InIdentifier(s)TopicPublished DateMatch?
DREADDs: novel tools for drug discovery and development[1]Hyeong-Min Lee, [2]Patrick M Giguere, [3]Bryan L Roth [Full author list]Drug Discovery Today [missing]DOI: 10.1016/J.DRUDIS.2013.10.018 [ORCID]
PubMed: 24184433 [ORCID]
drug discovery [missing]2013-11-01
Pharmacosynthetics: Reimagining the pharmacogenetic approach[1]Martilias S Farrell, [2]Bryan L Roth [Full author list]Brain Research [missing]DOI: 10.1016/J.BRAINRES.2012.09.043 [ORCID]
PubMed: 23063887 [ORCID]
2013-05-20
Securinine, a myeloid differentiation agent with therapeutic potential for AML[1]Kalpana Gupta, [2]Amitabha Chakrabarti, [3]Sonia Rana, [4]Ritu Ramdeo, [5]Bryan L Roth, [6]Munna L Agarwal, [7]William Tse, [8]Mukesh K Agarwal, [9]David N Wald [Full author list]PLOS One [missing]DOI: 10.1371/JOURNAL.PONE.0021203 [ORCID]
PubMed: 21731671 [ORCID]
2011-01-01
HTS and rational drug design to generate a class of 5-HT(2C)-selective ligands for possible use in schizophrenia[1]Alan P Kozikowski, [2]Sung Jin Cho, [3]Niels H Jensen, [4]John A Allen, [5]Andreas M Svennebring, [6]Bryan L Roth [Full author list]ChemMedChem [missing]DOI: 10.1002/CMDC.201000186 [ORCID]
PubMed: 20533502 [ORCID]
schizophrenia [missing]2010-08-01Bryan L. Roth (Q89688393; 44 items)
Pimavanserin tartrate: a 5-HT2A inverse agonist with potential for treating various neuropsychiatric disorders[1]Atheir Abbas, [2]Bryan L Roth [Full author list]Expert Opinion on Pharmacotherapy [missing]DOI: 10.1517/14656560802532707 [ORCID]
PubMed: 19040345 [ORCID]
tartrate [missing]; pimavanserin [missing]; pimavanserin tartrate [missing]2008-12-01
Engineering GPCR signaling pathways with RASSLs[1]Bruce R Conklin, [2]Edward C Hsiao, [3]Sylvie Claeysen, [4]Aline Dumuis, [5]Supriya Srinivasan, [6]John R Forsayeth, [7]Jean-Marc Guettier, [8]W C Chang, [9]Ying Pei, [10]Ken D McCarthy, [11]Robert A Nissenson, [12]Jürgen Wess, [13]Joël Bockaert, [14]Bryan L Roth [Full author list]Nature Methods [missing]DOI: 10.1038/NMETH.1232 [ORCID]
PubMed: 18668035 [ORCID]
cell biology [missing]; G protein-coupled receptor [missing]2008-08-01
Arresting serotonin[1]Atheir Abbas, [2]Bryan L Roth [Full author list]Proceedings of the National Academy of Sciences of the United States of America [missing]DOI: 10.1073/PNAS.0711335105 [ORCID]
PubMed: 18195368 [ORCID]
serotonin [missing]2008-01-22
Evolving the lock to fit the key to create a family of G protein-coupled receptors potently activated by an inert ligand[1]Blaine N Armbruster, [2]Xiang Li, [3]Mark H Pausch, [4]Stefan Herlitze, [5]Bryan L Roth [Full author list]Proceedings of the National Academy of Sciences of the United States of America [missing]DOI: 10.1073/PNAS.0700293104 [ORCID]
PubMed: 17360345 [ORCID]
G protein-coupled receptor [missing]2007-03-20
Drugs and valvular heart disease[1]Bryan L Roth [Full author list]The New England Journal of Medicine [missing]DOI: 10.1056/NEJMP068265 [ORCID]
PubMed: 17202450 [ORCID]
heart disease [missing]2007-01-04
WAY-100635 is a potent dopamine D4 receptor agonist[1]Benjamin R Chemel, [2]Bryan L Roth, [3]Blaine Armbruster, [4]Val J Watts, [5]David E Nichols [Full author list]Psychopharmacology [missing]DOI: 10.1007/S00213-006-0490-4 [ORCID]
PubMed: 16915381 [ORCID]
dopamine [missing]2006-10-01

Potential author items

NameDescriptionAuthored itemsIdentifiersEmployer(s)
Bryan L. RothAmerican pharmacologist44ORCID: 0000-0002-0561-6520
ISNI: 0000000055596359
VIAF ID: 75400848
Bryan RothAmerican businessman0
Bryan Rothcollege basketball player (1984–1985) Akron0University of Akron [missing]
Other Q number of this author

New Author Item

(if the author you are looking for is not listed above and otherwise not yet in Wikidata)
Author name:
Check ORCID for Bryan L Roth | Author has ORCID ID:
Check VIAF for Bryan L Roth | Author has VIAF ID:
Check ResearchGate for Bryan L Roth | Author has ResearchGate Profile ID:
After creating the new author item, enter the Wikidata ID in the "Other Q number of this author" field above to link to their works.

Author items in these papers

Common author name strings in these papers

Publishing venues for these papers

Topics for these papers


Feedback
Source and documentation (at github)
Wikidata page